Search Within

Genitourinary Oncology Service

  1. "2013"
Formats
  1. Meeting Abstract (125)
  2. Journal Article (94)
  3. Book Section (2)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (222)
  2. Solid Tumor Oncology Division (222)
  3. GSK Faculty (63)
  4. Human Oncology and Pathogenesis Program (40)
  5. Department of Pathology and Laboratory Medicine (39)
  6. Epidemiology and Biostatistics (39)

More Groups

People
  1. Howard Scher (62)
  2. Robert Motzer (57)
  3. Dean Bajorin (26)
  4. Dana Rathkopf (24)
  5. David Solit (22)
  6. Michael Morris (22)

More People

Years
  1. 2013 (222)
Publications
  1. Journal of Clinical Oncology (99)
  2. European Journal of Cancer (15)
  3. Cancer (6)
  4. Cancer Research (6)
  5. Clinical Cancer Research (6)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (102)
  2. Elsevier Inc. (25)
  3. American Association for Cancer Research (15)
  4. Nature Publishing Group (15)
  5. Elsevier Science, Inc. (13)
  6. Wiley Blackwell (10)

More Publishers

Results (222)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • General chemotherapy imaging
    Book Section

    Torrisi, J. M.; Iyriboz, T. A.; Xiao, H.
    In Bach, A. M.; Zhang, J. (Eds.) Atlas of Genitourinary Oncological Imaging (2013)

    Fulltext@MSK | Save
  • ARN-509 in men with high-risk nonmetastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W. R.; Shore, N.; Liu, G.; Alumkal, J. J.; Higano, C. S.; Maneval, E. C.; Rathkopf, D. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Outcomes in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial
    Meeting Abstract

    Sternberg, C. N.; De Bono, J. S.; Chi, K. N.; Fizazi, K.; Mulders, P.; Hirmand, M.; Forer, D.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Dissecting the therapeutic effects of anti-CTLA-4 and ADT in a murine hormone-sensitive prostate cancer
    Meeting Abstract

    Subudhi, S. K.; Montalvo-Ortiz, W.; Scher, H. I.; Allison, J. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of (177)lutetium radiolabeled anti-PSMA antibody J591 ((177)Lu-J591) for metastatic castrate-resistant prostate cancer (metCRPC): Survival update and expansion cohort with biomarkers
    Meeting Abstract

    Tagawa, S. T.; Akhtar, N. H.; Osborne, J.; Christos, P. J.; Vallabhajosula, S.; Goldsmith, S. J.; Kahn, R.; Ecker, C.; Beltran, H.; Morris, M. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events
    Meeting Abstract

    Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • ARN-509 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J. J.; Ryan, C. J.; Saleh, M. N.; Hauke, R. J.; Maneval, E. C.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Updated interim analysis (IA) of COU-AA-302, a randomized phase III study of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy
    Meeting Abstract

    Rathkopf, D. E.; Smith, M. R.; De Bono, J. S.; Logothetis, C.; Shore, N. D.; De Souza, P. L.; Fizazi, K.; Mulders, P.; Mainwaring, P. N.; Hainsworth, J. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Relationship of hypoxia signature with variant subgroup of clear cell renal cell carcinoma (ccRCC) and its association with clinical activity on tivozanib hydrochloride
    Meeting Abstract

    Robinson, M. O.; Feng, B.; Nicoletti, R.; Berkenblit, A.; Strahs, A. L.; Esteves, B.; Eisen, T.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic value of serum and rogens, by ultrasensitive assay, in metastatic castration-resistant prostate cancer (mCRPC): Phase III trial data
    Meeting Abstract

    Ryan, C. J.; Molina, A.; Li, J.; Kheoh, T. S.; Small, E. J.; Haqq, C. M.; Grant, R. P.; De Bono, J. S.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save